Recon: FDA adcomm gives thumbs up to GSK’s anemia drug; Italy alleges Pfizer hid $1.2B in profits

ReconReconBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy